565 related articles for article (PubMed ID: 22971110)
1. Proteomics approaches for myeloid leukemia drug discovery.
Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
[TBL] [Abstract][Full Text] [Related]
2. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of the human pituitary tissue: bioanalytical methods and applications.
Giorgianni F; Koirala D; Beranova-Giorgianni S
Bioanalysis; 2014; 6(14):1989-2003. PubMed ID: 25158968
[TBL] [Abstract][Full Text] [Related]
4. Chemoproteomic approaches to drug target identification and drug profiling.
Bantscheff M; Drewes G
Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
6. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
Roe MR; Griffin TJ
Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
[TBL] [Abstract][Full Text] [Related]
7. Development and application of proteomics technologies in Saccharomyces cerevisiae.
Kolkman A; Slijper M; Heck AJ
Trends Biotechnol; 2005 Dec; 23(12):598-604. PubMed ID: 16202464
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches in myeloid leukemia.
Kanaujiya JK; Lochab S; Pal P; Christopeit M; Singh SM; Sanyal S; Behre G; Trivedi AK
Electrophoresis; 2011 Feb; 32(3-4):357-67. PubMed ID: 21254132
[TBL] [Abstract][Full Text] [Related]
9. 2D-DIGE: comparative proteomics of cellular signalling pathways.
Larbi NB; Jefferies C
Methods Mol Biol; 2009; 517():105-32. PubMed ID: 19378013
[TBL] [Abstract][Full Text] [Related]
10. 2D electrophoresis-based expression proteomics: a microbiologist's perspective.
Sá-Correia I; Teixeira MC
Expert Rev Proteomics; 2010 Dec; 7(6):943-53. PubMed ID: 21142894
[TBL] [Abstract][Full Text] [Related]
11. Proteomics technologies for the global identification and quantification of proteins.
Brewis IA; Brennan P
Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in clinical proteomics using mass spectrometry.
Dowling P; Meleady P; Henry M; Clynes M
Bioanalysis; 2010 Sep; 2(9):1609-15. PubMed ID: 21083289
[TBL] [Abstract][Full Text] [Related]
13. Applying proteomics technology to platelet research.
García A; Watson SP; Dwek RA; Zitzmann N
Mass Spectrom Rev; 2005; 24(6):918-30. PubMed ID: 15599945
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric approaches for characterizing bacterial proteomes.
VerBerkmoes NC; Connelly HM; Pan C; Hettich RL
Expert Rev Proteomics; 2004 Dec; 1(4):433-47. PubMed ID: 15966840
[TBL] [Abstract][Full Text] [Related]
15. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
16. Towards functional genomics in fish using quantitative proteomics.
Martyniuk CJ; Denslow ND
Gen Comp Endocrinol; 2009; 164(2-3):135-41. PubMed ID: 19523377
[TBL] [Abstract][Full Text] [Related]
17. Methods of comparative proteomic profiling for disease diagnostics.
Steel LF; Haab BB; Hanash SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the rat urinary proteome with three complementary proteomics approaches.
Sánchez-Juanes F; Muñiz MC; Raposo C; Rodríguez-Prieto S; Paradela A; Quiros Y; López-Hernández F; González-Buitrago JM; Ferreira L
Electrophoresis; 2013 Sep; 34(17):2473-83. PubMed ID: 23784626
[TBL] [Abstract][Full Text] [Related]
20. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
